TIDMSN.

RNS Number : 6064Q

Smith & Nephew Plc

21 February 2023

SMITH & NEPHEW PLC

21 February 2023

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ('PDMR') AND PERSONS CLOSELY ASSOCIATED WITH THEM.

Smith & Nephew plc (the "Company") announces that it has been informed of changes to the share interests of PDMRs in the Company, detailed below, following completion of the related performance periods.

Smith & Nephew Global Share Plan 2020 (Performance Share Awards):

The following relates to individuals included in the below notification:

 
 Reason for the notification 
 Initial notification        Initial notification 
  /Amendment 
                            ------------------------------------------ 
 Details of the issuer, emission allowance market participant, 
  auction platform, auctioneer or auction monitor 
 Name                        Smith & Nephew plc 
                            ------------------------------------------ 
 LEI                         213800ZTMDN8S67S1H61 
                            ------------------------------------------ 
 Details of the transaction(s): section to be repeated for 
  (i) each type of instrument; (ii) each type of transaction; 
  (iii) each date; and (iv) each place where transactions have 
  been conducted 
 Description of the          Smith & Nephew plc ordinary shares of USD 
  financial instrument,       0.20 each 
  type of instrument 
                            ------------------------------------------ 
 Identification code         ISIN: GB0009223206 
                            ------------------------------------------ 
 Nature of the transaction   Lapse of Performance Share Awards granted 
                              on 21 May 2020 under the Smith & Nephew 
                              Global Share Plan 2020 
                            ------------------------------------------ 
 Date of Transaction         2023 - 02 - 21 
                            ------------------------------------------ 
 Place of Transaction        Lapse took place outside a trading venue 
                            ------------------------------------------ 
 
 
 Name of PDMR                  Number of ordinary    Number of ordinary    Number of ordinary 
  (Position)                    shares under          shares lapsed         shares outstanding 
                                award granted         under award           under award 
                                on 21/05/2020         (shown at maximum)    (shown at maximum) 
                                (shown at maximum) 
 Helen Barraclough 
  (Group General Counsel 
  & Company Secretary)                      10,982                10,982                     0 
                              --------------------  --------------------  -------------------- 
 Bradley Cannon 
  ( President Orthopaedics, 
  Sports Medicine 
  & ENT and Americas)                       29,624                29,624                     0 
                              --------------------  --------------------  -------------------- 
 Phil Cowdy 
  (Chief Corporate 
  Development & Corporate 
  Affairs Officer)                          19,860                19,860                     0 
                              --------------------  --------------------  -------------------- 
 Myra Eskes 
  (President APAC 
  Region & Global 
  Service)                                  29,392                29,392                     0 
                              --------------------  --------------------  -------------------- 
 Simon Fraser 
  (President Advanced 
  Wound Management 
  & Global Commercial 
  Operations)                               25,628                25,628                     0 
                              --------------------  --------------------  -------------------- 
 Elga Lohler 
  (Chief HR Officer)                        26,472                26,472                     0 
                              --------------------  --------------------  -------------------- 
 Vasant Padmanabhan 
  (President Research 
  & Development)                            25,638                25,638                     0 
                              --------------------  --------------------  --------------------

Notes:

(i) Following completion of the performance measurement period, these awards lapsed in full on 21 February 2023.

(ii) Details regarding the performance against targets as set at the grant date will be disclosed within the Annual Report which is to be published on 6 March 2023.

This announcement is made in accordance with the requirements of Article 19 (3) of the Market Abuse Regulation.

Sarah Carne

Deputy Company Secretary

Smith & Nephew plc

   Tel:      +44 (0) 1923 477100

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHFLFVVFTILFIV

(END) Dow Jones Newswires

February 21, 2023 08:41 ET (13:41 GMT)

Smith & Nephew (LSE:SN.)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Smith & Nephew Charts.
Smith & Nephew (LSE:SN.)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Smith & Nephew Charts.